Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Cholera.
J B Kaper; J G Morris; M M Levine (Profiled Authors: James B Kaper; Myron M Levine)
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore 21201.
Clinical microbiology reviews 1995;8(1):48-86.
Despite more than a century of study, cholera still presents challenges and surprises to us. Throughout most of the 20th century, cholera was caused by Vibrio cholerae of the O1 serogroup and the disease was largely confined to Asia and Africa. However, the last decade of the 20th century has witnessed two major developments in the history of this disease. In 1991, a massive outbreak of cholera started in South America, the one continent previously untouched by cholera in this century. In 1992, an apparently new pandemic caused by a previously unknown serogroup of V. cholerae (O139) began in India and Bangladesh. The O139 epidemic has been occurring in populations assumed to be largely immune to V. cholerae O1 and has rapidly spread to many countries including the United States. In this review, we discuss all aspects of cholera, including the clinical microbiology, epidemiology, pathogenesis, and clinical features of the disease. Special attention will be paid to the extraordinary advances that have been made in recent years in unravelling the molecular pathogenesis of this infection and in the development of new generations of vaccines to prevent it.
13 Originating Grant
-
1.
KAPER, JAMES B
Development of a Live Oral Cholera Vaccine
1 January 1983 - 30 June 2011
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
2.
KAPER, JAMES B
DEVELOPMENT OF A LIVE ORAL CHOLERA VACCINE
1 January 1983 - 31 December 1995
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
-
3.
LEVINE, MYRON M
-
4.
LEVINE, MYRON M
-
5.
LEVINE, MYRON M
-
6.
LEVINE, MYRON M
-
7.
LEVINE, MYRON M
-
8.
LEVINE, MYRON M
-
9.
LEVINE, MYRON M
-
10.
LEVINE, MYRON M
-
11.
LEVINE, MYRON M
-
12.
LEVINE, MYRON M
-
13.
LEVINE, MYRON M
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
1993J M Ketley; J Michalski; J Galen; M M Levine; J B Kaper
Construction of genetically marked Vibrio cholerae O1 vaccine strains.
FEMS microbiology letters 1993;111(1):15-21. -
2.
1992C O Tacket; G Losonsky; J P Nataro; S J Cryz; R Edelman; J B Kaper; M M Levine
The Journal of infectious diseases 1992;166(4):837-41. -
3.
1995S J Cryz; J Kaper; C Tacket; J Nataro; M M Levine
Developments in biological standardization 1995;84():237-44.

Appears in this Publication








